Angela Bryan
Concepts (530)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sexual Behavior | 42 | 2023 | 502 | 7.990 |
Why?
| | Exercise | 40 | 2026 | 2219 | 6.350 |
Why?
| | Risk-Taking | 27 | 2023 | 325 | 6.280 |
Why?
| | Cannabis | 25 | 2026 | 518 | 5.660 |
Why?
| | Adolescent Behavior | 24 | 2021 | 498 | 5.040 |
Why?
| | Condoms | 28 | 2021 | 102 | 4.660 |
Why?
| | Cannabidiol | 14 | 2026 | 142 | 4.550 |
Why?
| | Alcohol Drinking | 29 | 2025 | 858 | 4.480 |
Why?
| | Dronabinol | 21 | 2026 | 251 | 4.420 |
Why?
| | Marijuana Use | 13 | 2025 | 222 | 4.350 |
Why?
| | Marijuana Abuse | 17 | 2025 | 215 | 4.320 |
Why?
| | Sexually Transmitted Diseases | 18 | 2021 | 168 | 4.100 |
Why?
| | Juvenile Delinquency | 16 | 2016 | 95 | 3.780 |
Why?
| | Intention | 15 | 2021 | 187 | 3.620 |
Why?
| | Affect | 15 | 2026 | 323 | 3.510 |
Why?
| | Marijuana Smoking | 15 | 2023 | 249 | 3.360 |
Why?
| | Motivation | 26 | 2026 | 616 | 2.770 |
Why?
| | Substance-Related Disorders | 16 | 2023 | 1112 | 2.550 |
Why?
| | Health Behavior | 18 | 2023 | 799 | 2.340 |
Why?
| | Risk Reduction Behavior | 8 | 2021 | 221 | 2.280 |
Why?
| | Health Promotion | 12 | 2026 | 792 | 2.190 |
Why?
| | Attitude | 8 | 2021 | 260 | 2.100 |
Why?
| | HIV Infections | 22 | 2023 | 3235 | 1.940 |
Why?
| | Adolescent | 95 | 2025 | 22826 | 1.860 |
Why?
| | Sexual and Gender Minorities | 4 | 2024 | 272 | 1.840 |
Why?
| | Young Adult | 69 | 2026 | 14437 | 1.830 |
Why?
| | Female | 159 | 2026 | 80081 | 1.800 |
Why?
| | Exercise Therapy | 7 | 2026 | 489 | 1.780 |
Why?
| | Male | 149 | 2026 | 73954 | 1.770 |
Why?
| | Humans | 200 | 2026 | 147306 | 1.640 |
Why?
| | Unsafe Sex | 7 | 2018 | 62 | 1.620 |
Why?
| | Brain | 17 | 2020 | 3009 | 1.540 |
Why?
| | Psychological Theory | 7 | 2021 | 96 | 1.510 |
Why?
| | Self Efficacy | 11 | 2018 | 423 | 1.510 |
Why?
| | Adult | 100 | 2026 | 41406 | 1.470 |
Why?
| | Health Knowledge, Attitudes, Practice | 11 | 2020 | 1431 | 1.440 |
Why?
| | Body Mass Index | 8 | 2024 | 2470 | 1.350 |
Why?
| | Anxiety | 6 | 2026 | 1149 | 1.340 |
Why?
| | Cognition | 8 | 2023 | 1286 | 1.340 |
Why?
| | Prisoners | 6 | 2018 | 145 | 1.340 |
Why?
| | Cross-Over Studies | 2 | 2023 | 617 | 1.320 |
Why?
| | Homosexuality, Male | 4 | 2023 | 234 | 1.290 |
Why?
| | Pain | 3 | 2026 | 794 | 1.240 |
Why?
| | Hallucinogens | 9 | 2024 | 112 | 1.220 |
Why?
| | Safe Sex | 7 | 2020 | 24 | 1.180 |
Why?
| | Diet | 4 | 2024 | 1284 | 1.110 |
Why?
| | Alcoholism | 14 | 2023 | 838 | 1.050 |
Why?
| | Fruit | 2 | 2019 | 146 | 1.050 |
Why?
| | Vegetables | 2 | 2019 | 162 | 1.030 |
Why?
| | Mindfulness | 4 | 2024 | 136 | 1.030 |
Why?
| | Anti-Anxiety Agents | 2 | 2026 | 48 | 1.020 |
Why?
| | Personal Satisfaction | 2 | 2024 | 221 | 1.010 |
Why?
| | Magnetic Resonance Imaging | 22 | 2021 | 3980 | 0.980 |
Why?
| | Attitude to Health | 6 | 2018 | 431 | 0.940 |
Why?
| | Models, Statistical | 3 | 2026 | 677 | 0.930 |
Why?
| | Interpersonal Relations | 2 | 2024 | 403 | 0.930 |
Why?
| | Running | 3 | 2023 | 234 | 0.900 |
Why?
| | Emotions | 4 | 2025 | 583 | 0.890 |
Why?
| | Surveys and Questionnaires | 31 | 2025 | 6164 | 0.890 |
Why?
| | Puberty | 2 | 2018 | 137 | 0.880 |
Why?
| | Middle Aged | 49 | 2026 | 36821 | 0.870 |
Why?
| | Behavioral Medicine | 2 | 2023 | 39 | 0.860 |
Why?
| | DNA Methylation | 6 | 2024 | 722 | 0.860 |
Why?
| | Saliva | 4 | 2025 | 252 | 0.860 |
Why?
| | Cannabinoids | 6 | 2026 | 184 | 0.840 |
Why?
| | Alcohol-Related Disorders | 6 | 2021 | 126 | 0.840 |
Why?
| | Longitudinal Studies | 16 | 2026 | 3029 | 0.840 |
Why?
| | Yoga | 1 | 2024 | 31 | 0.830 |
Why?
| | Feeding Behavior | 4 | 2019 | 693 | 0.830 |
Why?
| | Community-Based Participatory Research | 1 | 2026 | 174 | 0.820 |
Why?
| | Overweight | 3 | 2021 | 617 | 0.810 |
Why?
| | Brain Mapping | 6 | 2018 | 550 | 0.810 |
Why?
| | Decision Making | 5 | 2018 | 994 | 0.810 |
Why?
| | Physical Fitness | 4 | 2020 | 209 | 0.800 |
Why?
| | Health Education | 7 | 2009 | 346 | 0.790 |
Why?
| | Flowers | 6 | 2026 | 61 | 0.790 |
Why?
| | Sleep | 3 | 2026 | 895 | 0.790 |
Why?
| | Posture | 1 | 2024 | 197 | 0.770 |
Why?
| | Pain Management | 2 | 2026 | 415 | 0.740 |
Why?
| | Underage Drinking | 3 | 2021 | 22 | 0.740 |
Why?
| | Cues | 5 | 2019 | 329 | 0.730 |
Why?
| | Motor Activity | 3 | 2026 | 719 | 0.720 |
Why?
| | Reward | 5 | 2018 | 248 | 0.710 |
Why?
| | Sexual Health | 1 | 2023 | 68 | 0.710 |
Why?
| | Coitus | 2 | 2020 | 24 | 0.700 |
Why?
| | Survivors | 1 | 2026 | 528 | 0.700 |
Why?
| | Depression | 3 | 2025 | 1599 | 0.690 |
Why?
| | Smoking Cessation | 4 | 2017 | 441 | 0.680 |
Why?
| | Executive Function | 5 | 2020 | 472 | 0.680 |
Why?
| | Students | 11 | 2021 | 659 | 0.670 |
Why?
| | Medical Marijuana | 2 | 2020 | 122 | 0.660 |
Why?
| | Behavior Therapy | 4 | 2023 | 297 | 0.650 |
Why?
| | Varenicline | 2 | 2017 | 28 | 0.640 |
Why?
| | High-Intensity Interval Training | 1 | 2020 | 45 | 0.620 |
Why?
| | Sexual Partners | 3 | 2024 | 195 | 0.620 |
Why?
| | Attentional Bias | 1 | 2019 | 10 | 0.600 |
Why?
| | Attention | 3 | 2020 | 464 | 0.600 |
Why?
| | Parietal Lobe | 2 | 2019 | 62 | 0.590 |
Why?
| | Sex Offenses | 2 | 2020 | 199 | 0.590 |
Why?
| | Prisons | 2 | 2013 | 87 | 0.590 |
Why?
| | Irritable Bowel Syndrome | 1 | 2019 | 29 | 0.580 |
Why?
| | Models, Psychological | 9 | 2018 | 295 | 0.570 |
Why?
| | Delay Discounting | 2 | 2018 | 29 | 0.560 |
Why?
| | Motivational Interviewing | 4 | 2023 | 122 | 0.550 |
Why?
| | Sex Education | 2 | 2016 | 35 | 0.550 |
Why?
| | Cocaine-Related Disorders | 1 | 2019 | 133 | 0.540 |
Why?
| | Reaction Time | 2 | 2019 | 438 | 0.530 |
Why?
| | Limbic System | 1 | 2018 | 55 | 0.530 |
Why?
| | Body Weight Maintenance | 1 | 2017 | 18 | 0.520 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 512 | 0.520 |
Why?
| | Obesity | 5 | 2023 | 3149 | 0.520 |
Why?
| | Colorado | 14 | 2026 | 4591 | 0.520 |
Why?
| | Adolescent Development | 1 | 2018 | 73 | 0.520 |
Why?
| | Public Policy | 3 | 2026 | 81 | 0.520 |
Why?
| | Nerve Net | 2 | 2018 | 288 | 0.510 |
Why?
| | Smoking | 7 | 2017 | 1483 | 0.510 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2019 | 185 | 0.500 |
Why?
| | Mental Health | 2 | 2026 | 813 | 0.500 |
Why?
| | Tobacco Use Disorder | 2 | 2017 | 217 | 0.500 |
Why?
| | Sequence Analysis, DNA | 1 | 2020 | 780 | 0.500 |
Why?
| | Homosexuality, Female | 2 | 2015 | 42 | 0.490 |
Why?
| | Aggression | 3 | 2015 | 180 | 0.490 |
Why?
| | Cerebral Cortex | 2 | 2018 | 483 | 0.490 |
Why?
| | Inflammation | 3 | 2025 | 2921 | 0.490 |
Why?
| | Insulin Resistance | 1 | 2025 | 1253 | 0.480 |
Why?
| | Genotype | 8 | 2014 | 1875 | 0.480 |
Why?
| | Corpus Striatum | 1 | 2018 | 181 | 0.480 |
Why?
| | Crime Victims | 2 | 2018 | 133 | 0.470 |
Why?
| | Feedback, Psychological | 1 | 2016 | 24 | 0.470 |
Why?
| | Follow-Up Studies | 13 | 2018 | 5478 | 0.470 |
Why?
| | Cognitive Neuroscience | 1 | 2016 | 9 | 0.460 |
Why?
| | Video Games | 1 | 2016 | 30 | 0.460 |
Why?
| | Research Design | 5 | 2019 | 1158 | 0.460 |
Why?
| | Neoplasms | 3 | 2026 | 2946 | 0.450 |
Why?
| | Psychotherapy | 1 | 2017 | 184 | 0.450 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2017 | 434 | 0.450 |
Why?
| | Feeding and Eating Disorders | 2 | 2014 | 168 | 0.440 |
Why?
| | Temporal Lobe | 1 | 2015 | 113 | 0.430 |
Why?
| | Criminals | 2 | 2014 | 34 | 0.430 |
Why?
| | Psychometrics | 7 | 2025 | 739 | 0.430 |
Why?
| | Coercion | 1 | 2014 | 9 | 0.430 |
Why?
| | Shame | 1 | 2014 | 12 | 0.420 |
Why?
| | Risk Factors | 14 | 2017 | 11017 | 0.420 |
Why?
| | United States | 16 | 2026 | 16313 | 0.420 |
Why?
| | Research Subjects | 1 | 2014 | 41 | 0.420 |
Why?
| | Love | 2 | 2011 | 14 | 0.420 |
Why?
| | Brain-Derived Neurotrophic Factor | 3 | 2014 | 155 | 0.420 |
Why?
| | Gymnastics | 1 | 2014 | 20 | 0.420 |
Why?
| | Body Image | 2 | 2014 | 97 | 0.420 |
Why?
| | Criminal Law | 1 | 2014 | 31 | 0.410 |
Why?
| | Psychotherapy, Group | 3 | 2009 | 79 | 0.410 |
Why?
| | Bacteria | 1 | 2020 | 769 | 0.410 |
Why?
| | Mental Disorders | 2 | 2019 | 1188 | 0.410 |
Why?
| | Patient Dropouts | 1 | 2014 | 67 | 0.410 |
Why?
| | Oxygen Consumption | 3 | 2023 | 721 | 0.400 |
Why?
| | Trust | 1 | 2015 | 163 | 0.390 |
Why?
| | Self Report | 7 | 2021 | 887 | 0.390 |
Why?
| | Physical Exertion | 4 | 2023 | 205 | 0.390 |
Why?
| | Program Evaluation | 4 | 2013 | 952 | 0.380 |
Why?
| | Aged | 15 | 2026 | 26516 | 0.380 |
Why?
| | Mobile Applications | 1 | 2016 | 199 | 0.380 |
Why?
| | Patient Compliance | 2 | 2014 | 591 | 0.380 |
Why?
| | Regression Analysis | 6 | 2016 | 1003 | 0.380 |
Why?
| | Biomedical Research | 1 | 2019 | 723 | 0.370 |
Why?
| | Task Performance and Analysis | 2 | 2015 | 203 | 0.360 |
Why?
| | Breast Neoplasms | 2 | 2017 | 2420 | 0.360 |
Why?
| | Social Norms | 3 | 2018 | 31 | 0.360 |
Why?
| | Heterosexuality | 3 | 2011 | 49 | 0.360 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2026 | 1777 | 0.350 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 773 | 0.350 |
Why?
| | Cell Phone | 1 | 2012 | 83 | 0.340 |
Why?
| | Substance Abuse Treatment Centers | 1 | 2012 | 49 | 0.340 |
Why?
| | Receptors, Dopamine D2 | 4 | 2018 | 93 | 0.340 |
Why?
| | Heart Rate | 4 | 2026 | 860 | 0.340 |
Why?
| | Social Desirability | 1 | 2011 | 13 | 0.330 |
Why?
| | Courtship | 1 | 2011 | 11 | 0.330 |
Why?
| | Cross-Sectional Studies | 10 | 2021 | 6011 | 0.330 |
Why?
| | Social Dominance | 1 | 2011 | 16 | 0.330 |
Why?
| | Weight Loss | 2 | 2021 | 867 | 0.320 |
Why?
| | Self-Control | 2 | 2024 | 56 | 0.320 |
Why?
| | Peer Group | 4 | 2020 | 258 | 0.320 |
Why?
| | Health Risk Behaviors | 2 | 2020 | 14 | 0.320 |
Why?
| | Factor Analysis, Statistical | 5 | 2025 | 296 | 0.320 |
Why?
| | Gray Matter | 3 | 2021 | 97 | 0.320 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1339 | 0.320 |
Why?
| | Reproducibility of Results | 11 | 2025 | 3448 | 0.310 |
Why?
| | Research | 3 | 2015 | 435 | 0.300 |
Why?
| | Genomics | 2 | 2012 | 839 | 0.300 |
Why?
| | Universities | 5 | 2020 | 453 | 0.300 |
Why?
| | Cancer Survivors | 2 | 2026 | 347 | 0.290 |
Why?
| | Adaptation, Psychological | 1 | 2014 | 736 | 0.280 |
Why?
| | Polymorphism, Single Nucleotide | 5 | 2014 | 2223 | 0.280 |
Why?
| | Phenotype | 6 | 2022 | 3216 | 0.280 |
Why?
| | White Matter | 2 | 2021 | 170 | 0.270 |
Why?
| | Impulsive Behavior | 5 | 2017 | 145 | 0.260 |
Why?
| | Psychotic Disorders | 2 | 2022 | 199 | 0.260 |
Why?
| | Urban Population | 2 | 2009 | 502 | 0.260 |
Why?
| | Testosterone | 1 | 2011 | 417 | 0.250 |
Why?
| | Software | 1 | 2012 | 683 | 0.250 |
Why?
| | Aging | 3 | 2026 | 1992 | 0.250 |
Why?
| | Antipsychotic Agents | 2 | 2022 | 211 | 0.250 |
Why?
| | Interviews as Topic | 3 | 2026 | 932 | 0.250 |
Why?
| | Individuality | 2 | 2009 | 149 | 0.250 |
Why?
| | Fatigue | 3 | 2016 | 367 | 0.240 |
Why?
| | Prospective Studies | 6 | 2018 | 8166 | 0.230 |
Why?
| | Age Factors | 7 | 2026 | 3372 | 0.230 |
Why?
| | Sex Factors | 8 | 2025 | 2136 | 0.230 |
Why?
| | Life Style | 3 | 2017 | 504 | 0.230 |
Why?
| | Pilot Projects | 4 | 2022 | 1912 | 0.220 |
Why?
| | Endocannabinoids | 1 | 2026 | 56 | 0.220 |
Why?
| | Treatment Outcome | 12 | 2022 | 11947 | 0.220 |
Why?
| | Community-Institutional Relations | 1 | 2026 | 101 | 0.220 |
Why?
| | Eicosanoids | 1 | 2025 | 58 | 0.220 |
Why?
| | Gender Identity | 2 | 2023 | 133 | 0.220 |
Why?
| | Cardiorespiratory Fitness | 1 | 2025 | 75 | 0.210 |
Why?
| | Cluster Analysis | 2 | 2018 | 502 | 0.210 |
Why?
| | Psilocybin | 1 | 2024 | 5 | 0.210 |
Why?
| | Meditation | 1 | 2024 | 34 | 0.210 |
Why?
| | Loneliness | 1 | 2025 | 69 | 0.210 |
Why?
| | Autonomic Nervous System | 1 | 2024 | 83 | 0.210 |
Why?
| | Progesterone | 1 | 2025 | 215 | 0.200 |
Why?
| | Pleasure | 1 | 2023 | 18 | 0.200 |
Why?
| | Minority Health | 1 | 2023 | 18 | 0.200 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 2024 | 118 | 0.200 |
Why?
| | Logistic Models | 2 | 2007 | 2142 | 0.190 |
Why?
| | Hydrocortisone | 1 | 2025 | 300 | 0.190 |
Why?
| | Body Weight | 2 | 2017 | 976 | 0.190 |
Why?
| | Double-Blind Method | 3 | 2024 | 2080 | 0.190 |
Why?
| | Cooking | 1 | 2023 | 62 | 0.180 |
Why?
| | Automobile Driving | 2 | 2007 | 159 | 0.180 |
Why?
| | Cooperative Behavior | 1 | 2026 | 471 | 0.180 |
Why?
| | Ethanol | 3 | 2021 | 634 | 0.180 |
Why?
| | Weight Lifting | 1 | 2002 | 31 | 0.180 |
Why?
| | Exercise Test | 2 | 2017 | 636 | 0.180 |
Why?
| | Exploratory Behavior | 4 | 2015 | 85 | 0.170 |
Why?
| | Effect Modifier, Epidemiologic | 1 | 2021 | 8 | 0.170 |
Why?
| | Anti-Inflammatory Agents | 1 | 2025 | 481 | 0.170 |
Why?
| | Analysis of Variance | 5 | 2011 | 1302 | 0.170 |
Why?
| | Prevalence | 4 | 2024 | 2889 | 0.170 |
Why?
| | Tobacco Use | 2 | 2019 | 68 | 0.170 |
Why?
| | Receptors, Dopamine D4 | 4 | 2009 | 27 | 0.160 |
Why?
| | Peer Influence | 1 | 2020 | 14 | 0.160 |
Why?
| | Sexuality | 2 | 1997 | 32 | 0.160 |
Why?
| | Sleep Wake Disorders | 1 | 2024 | 315 | 0.160 |
Why?
| | Multivariate Analysis | 3 | 2012 | 1550 | 0.160 |
Why?
| | Sensation Disorders | 1 | 2020 | 40 | 0.160 |
Why?
| | Occupations | 1 | 2000 | 51 | 0.150 |
Why?
| | Ecological Momentary Assessment | 1 | 2020 | 49 | 0.150 |
Why?
| | DNA, Ribosomal | 1 | 2020 | 84 | 0.150 |
Why?
| | Neuropsychological Tests | 4 | 2018 | 1145 | 0.150 |
Why?
| | Appetite | 1 | 2020 | 80 | 0.150 |
Why?
| | Occupational Diseases | 1 | 2001 | 165 | 0.150 |
Why?
| | Behavior, Addictive | 2 | 2019 | 89 | 0.150 |
Why?
| | Heroin Dependence | 1 | 2000 | 33 | 0.150 |
Why?
| | Socioeconomic Factors | 3 | 2015 | 1342 | 0.150 |
Why?
| | CpG Islands | 2 | 2017 | 176 | 0.150 |
Why?
| | Drug and Narcotic Control | 1 | 2019 | 24 | 0.150 |
Why?
| | Aged, 80 and over | 2 | 2025 | 8432 | 0.150 |
Why?
| | Diet Surveys | 1 | 2019 | 91 | 0.150 |
Why?
| | Knowledge | 1 | 2019 | 62 | 0.150 |
Why?
| | Self Concept | 2 | 2014 | 259 | 0.140 |
Why?
| | Migraine Disorders | 1 | 2020 | 115 | 0.140 |
Why?
| | Statistics as Topic | 2 | 2012 | 285 | 0.140 |
Why?
| | DNA, Bacterial | 1 | 2020 | 320 | 0.140 |
Why?
| | Plant Extracts | 1 | 2020 | 191 | 0.140 |
Why?
| | Social Behavior | 2 | 2018 | 287 | 0.140 |
Why?
| | Hostility | 2 | 2015 | 16 | 0.140 |
Why?
| | Suicidal Ideation | 1 | 2024 | 590 | 0.140 |
Why?
| | Self Disclosure | 2 | 2009 | 61 | 0.140 |
Why?
| | Methadone | 1 | 2000 | 131 | 0.130 |
Why?
| | Taste | 2 | 2018 | 238 | 0.130 |
Why?
| | Qualitative Research | 1 | 2026 | 1735 | 0.130 |
Why?
| | Anger | 2 | 2015 | 61 | 0.130 |
Why?
| | Hyperkinesis | 1 | 2017 | 16 | 0.130 |
Why?
| | Polymorphism, Genetic | 3 | 2008 | 615 | 0.130 |
Why?
| | Chronic Pain | 1 | 2022 | 301 | 0.130 |
Why?
| | Internal-External Control | 1 | 1997 | 74 | 0.130 |
Why?
| | Drinking | 1 | 2017 | 44 | 0.130 |
Why?
| | Information Dissemination | 1 | 2019 | 227 | 0.130 |
Why?
| | Cytokines | 1 | 2025 | 2087 | 0.130 |
Why?
| | Cannabinoid Receptor Agonists | 3 | 2021 | 44 | 0.120 |
Why?
| | Cigarette Smoking | 1 | 2018 | 103 | 0.120 |
Why?
| | Alcoholic Beverages | 1 | 2017 | 32 | 0.120 |
Why?
| | Stress, Psychological | 1 | 2025 | 1174 | 0.120 |
Why?
| | Single Person | 1 | 1996 | 6 | 0.120 |
Why?
| | Transcriptome | 1 | 2023 | 1059 | 0.120 |
Why?
| | Psychiatric Status Rating Scales | 3 | 2014 | 537 | 0.120 |
Why?
| | Prefrontal Cortex | 1 | 2019 | 342 | 0.120 |
Why?
| | Nicotinic Agonists | 1 | 2017 | 135 | 0.120 |
Why?
| | Southwestern United States | 2 | 2017 | 93 | 0.120 |
Why?
| | Nutrition Surveys | 1 | 2017 | 279 | 0.120 |
Why?
| | Nucleus Accumbens | 2 | 2015 | 136 | 0.110 |
Why?
| | Social Discrimination | 1 | 2015 | 9 | 0.110 |
Why?
| | Conduct Disorder | 1 | 2017 | 158 | 0.110 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 506 | 0.110 |
Why?
| | Social Justice | 1 | 2016 | 82 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 1 | 2004 | 2458 | 0.110 |
Why?
| | Mental Recall | 1 | 2016 | 225 | 0.110 |
Why?
| | Neuroimaging | 1 | 2017 | 309 | 0.110 |
Why?
| | Incidence | 2 | 2020 | 2954 | 0.110 |
Why?
| | Protective Factors | 1 | 2014 | 102 | 0.100 |
Why?
| | Athletic Performance | 1 | 2015 | 78 | 0.100 |
Why?
| | Goals | 1 | 2016 | 186 | 0.100 |
Why?
| | Cognitive Dysfunction | 1 | 2020 | 479 | 0.100 |
Why?
| | Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2013 | 25 | 0.100 |
Why?
| | Retinal Dehydrogenase | 1 | 2013 | 29 | 0.100 |
Why?
| | Anisotropy | 1 | 2013 | 78 | 0.100 |
Why?
| | Personality Inventory | 4 | 2011 | 134 | 0.100 |
Why?
| | Epigenesis, Genetic | 2 | 2024 | 708 | 0.100 |
Why?
| | Diffusion Tensor Imaging | 1 | 2013 | 83 | 0.100 |
Why?
| | Benzodiazepines | 1 | 2014 | 169 | 0.100 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2013 | 48 | 0.100 |
Why?
| | Models, Economic | 1 | 2013 | 64 | 0.090 |
Why?
| | Norepinephrine | 1 | 2013 | 201 | 0.090 |
Why?
| | India | 3 | 2007 | 221 | 0.090 |
Why?
| | Body Temperature | 1 | 2013 | 229 | 0.090 |
Why?
| | Auditory Perception | 1 | 2013 | 115 | 0.090 |
Why?
| | Microbiota | 1 | 2020 | 736 | 0.090 |
Why?
| | Body Weights and Measures | 1 | 2012 | 37 | 0.090 |
Why?
| | Lactic Acid | 1 | 2013 | 295 | 0.090 |
Why?
| | Connecticut | 3 | 2008 | 25 | 0.090 |
Why?
| | Artifacts | 1 | 2013 | 144 | 0.090 |
Why?
| | Comorbidity | 2 | 2012 | 1672 | 0.090 |
Why?
| | Residential Treatment | 1 | 2012 | 30 | 0.090 |
Why?
| | Speech | 1 | 2012 | 76 | 0.090 |
Why?
| | Nursing Research | 1 | 2012 | 49 | 0.090 |
Why?
| | Interview, Psychological | 1 | 2012 | 95 | 0.090 |
Why?
| | Biomarkers | 3 | 2025 | 4354 | 0.090 |
Why?
| | Receptor, Muscarinic M2 | 1 | 2011 | 10 | 0.090 |
Why?
| | Visual Perception | 1 | 2013 | 184 | 0.090 |
Why?
| | Sampling Studies | 1 | 2011 | 98 | 0.080 |
Why?
| | Secondary Prevention | 2 | 2023 | 253 | 0.080 |
Why?
| | Minnesota | 1 | 2012 | 168 | 0.080 |
Why?
| | Sex Characteristics | 2 | 2021 | 799 | 0.080 |
Why?
| | Radiography | 1 | 2014 | 862 | 0.080 |
Why?
| | Genetic Markers | 1 | 2012 | 338 | 0.080 |
Why?
| | Authoritarianism | 1 | 2011 | 12 | 0.080 |
Why?
| | Child | 5 | 2015 | 22980 | 0.080 |
Why?
| | Beauty | 1 | 2011 | 19 | 0.080 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2013 | 297 | 0.080 |
Why?
| | Cost-Benefit Analysis | 1 | 2013 | 654 | 0.080 |
Why?
| | Odorants | 1 | 2011 | 114 | 0.080 |
Why?
| | Anorexia Nervosa | 1 | 2011 | 82 | 0.080 |
Why?
| | Cognition Disorders | 1 | 2014 | 551 | 0.080 |
Why?
| | Smell | 1 | 2011 | 130 | 0.080 |
Why?
| | Forecasting | 1 | 2011 | 391 | 0.080 |
Why?
| | Menstrual Cycle | 1 | 2011 | 145 | 0.080 |
Why?
| | Photic Stimulation | 2 | 2013 | 266 | 0.080 |
Why?
| | Genome, Human | 1 | 2012 | 426 | 0.070 |
Why?
| | Craving | 2 | 2023 | 42 | 0.070 |
Why?
| | Genetic Variation | 2 | 2012 | 995 | 0.070 |
Why?
| | Minisatellite Repeats | 3 | 2008 | 36 | 0.070 |
Why?
| | Pregnancy in Adolescence | 1 | 2009 | 83 | 0.070 |
Why?
| | Biological Evolution | 1 | 2012 | 473 | 0.070 |
Why?
| | Psychotherapy, Brief | 1 | 2009 | 41 | 0.070 |
Why?
| | Alcoholic Intoxication | 1 | 2009 | 77 | 0.070 |
Why?
| | Internet | 1 | 2013 | 696 | 0.070 |
Why?
| | Recurrence | 1 | 2012 | 1151 | 0.070 |
Why?
| | Proteins | 1 | 2013 | 1024 | 0.060 |
Why?
| | Social Conformity | 1 | 2007 | 11 | 0.060 |
Why?
| | Computers | 1 | 2007 | 66 | 0.060 |
Why?
| | Quality of Life | 2 | 2026 | 3246 | 0.060 |
Why?
| | Exons | 1 | 2008 | 365 | 0.060 |
Why?
| | Motor Vehicles | 1 | 2007 | 30 | 0.060 |
Why?
| | Homoserine | 1 | 2006 | 6 | 0.060 |
Why?
| | Blood Pressure | 1 | 2013 | 1785 | 0.060 |
Why?
| | Judgment | 1 | 2007 | 59 | 0.060 |
Why?
| | 4-Butyrolactone | 1 | 2006 | 23 | 0.060 |
Why?
| | Adoption | 1 | 2006 | 25 | 0.060 |
Why?
| | Body Temperature Regulation | 1 | 2007 | 106 | 0.060 |
Why?
| | Lipoxygenase | 1 | 2025 | 15 | 0.060 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2007 | 237 | 0.060 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 2025 | 76 | 0.060 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 369 | 0.060 |
Why?
| | South Africa | 1 | 2006 | 269 | 0.060 |
Why?
| | Actigraphy | 1 | 2026 | 148 | 0.050 |
Why?
| | Functional Neuroimaging | 2 | 2017 | 62 | 0.050 |
Why?
| | Random Allocation | 1 | 2026 | 366 | 0.050 |
Why?
| | Reflex, Startle | 1 | 2005 | 75 | 0.050 |
Why?
| | Receptors, Nicotinic | 1 | 2007 | 328 | 0.050 |
Why?
| | Calcium Signaling | 1 | 2006 | 246 | 0.050 |
Why?
| | Hippocampus | 2 | 2022 | 989 | 0.050 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2025 | 163 | 0.050 |
Why?
| | Social Perception | 1 | 2005 | 104 | 0.050 |
Why?
| | Patient Education as Topic | 2 | 2009 | 781 | 0.050 |
Why?
| | Environment | 1 | 2006 | 297 | 0.050 |
Why?
| | Risk | 1 | 2007 | 927 | 0.050 |
Why?
| | Food Preferences | 2 | 2017 | 126 | 0.050 |
Why?
| | Cold Temperature | 1 | 2025 | 207 | 0.050 |
Why?
| | Pseudomonas aeruginosa | 1 | 2006 | 397 | 0.050 |
Why?
| | Social Class | 1 | 2025 | 266 | 0.050 |
Why?
| | Minority Groups | 1 | 2025 | 286 | 0.050 |
Why?
| | Models, Theoretical | 2 | 2008 | 563 | 0.050 |
Why?
| | Patient Satisfaction | 2 | 2009 | 718 | 0.050 |
Why?
| | Habits | 1 | 2023 | 52 | 0.050 |
Why?
| | Contraception Behavior | 2 | 2018 | 108 | 0.050 |
Why?
| | New Mexico | 2 | 2014 | 105 | 0.050 |
Why?
| | Gene Frequency | 1 | 2004 | 498 | 0.050 |
Why?
| | Genetics, Population | 1 | 2004 | 226 | 0.050 |
Why?
| | Child Behavior | 1 | 2004 | 238 | 0.050 |
Why?
| | Chi-Square Distribution | 2 | 2009 | 528 | 0.050 |
Why?
| | Time Factors | 2 | 2011 | 7173 | 0.050 |
Why?
| | Smokers | 1 | 2023 | 139 | 0.040 |
Why?
| | Pregnancy | 3 | 2012 | 7276 | 0.040 |
Why?
| | Risk Assessment | 1 | 2011 | 3784 | 0.040 |
Why?
| | Agoraphobia | 1 | 2001 | 9 | 0.040 |
Why?
| | Patient Acceptance of Health Care | 2 | 2012 | 895 | 0.040 |
Why?
| | Physicians, Women | 1 | 2002 | 91 | 0.040 |
Why?
| | Models, Genetic | 1 | 2004 | 536 | 0.040 |
Why?
| | Georgia | 1 | 2021 | 80 | 0.040 |
Why?
| | Harm Reduction | 1 | 2021 | 49 | 0.040 |
Why?
| | Exercise Tolerance | 1 | 2023 | 289 | 0.040 |
Why?
| | Eating | 2 | 2014 | 387 | 0.040 |
Why?
| | Psychomotor Disorders | 1 | 2020 | 15 | 0.040 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2001 | 61 | 0.040 |
Why?
| | Algorithms | 1 | 2008 | 1868 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2015 | 794 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2015 | 2030 | 0.040 |
Why?
| | Suicide, Attempted | 1 | 2024 | 430 | 0.040 |
Why?
| | Verbal Learning | 1 | 2020 | 73 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2024 | 784 | 0.040 |
Why?
| | School Health Services | 1 | 2002 | 222 | 0.040 |
Why?
| | Residence Characteristics | 1 | 2022 | 387 | 0.040 |
Why?
| | Spouses | 1 | 2000 | 109 | 0.040 |
Why?
| | Quality Indicators, Health Care | 1 | 2021 | 337 | 0.030 |
Why?
| | Substance Abuse, Intravenous | 1 | 2000 | 131 | 0.030 |
Why?
| | Methylation | 1 | 2018 | 242 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2024 | 840 | 0.030 |
Why?
| | Placebo Effect | 1 | 2017 | 24 | 0.030 |
Why?
| | Psychomotor Performance | 1 | 2020 | 326 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2022 | 590 | 0.030 |
Why?
| | Achievement | 1 | 2018 | 58 | 0.030 |
Why?
| | Tobacco Smoking | 1 | 2017 | 28 | 0.030 |
Why?
| | Benzazepines | 1 | 2017 | 35 | 0.030 |
Why?
| | Personality Assessment | 1 | 1997 | 79 | 0.030 |
Why?
| | Social Adjustment | 1 | 2017 | 64 | 0.030 |
Why?
| | Postural Balance | 1 | 2020 | 254 | 0.030 |
Why?
| | Beverages | 1 | 2017 | 68 | 0.030 |
Why?
| | Organ Size | 1 | 2017 | 465 | 0.030 |
Why?
| | Family | 1 | 2001 | 690 | 0.030 |
Why?
| | Self-Assessment | 1 | 1996 | 75 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2004 | 3660 | 0.030 |
Why?
| | Anticipation, Psychological | 1 | 2015 | 20 | 0.030 |
Why?
| | Smoking Prevention | 2 | 2007 | 167 | 0.030 |
Why?
| | Drive | 1 | 2014 | 2 | 0.030 |
Why?
| | Anesthesia Recovery Period | 1 | 1994 | 28 | 0.030 |
Why?
| | Anesthesia, Inhalation | 1 | 1994 | 14 | 0.030 |
Why?
| | Anesthesia, Intravenous | 1 | 1994 | 24 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1720 | 0.030 |
Why?
| | Bulimia | 1 | 2014 | 36 | 0.030 |
Why?
| | Energy Intake | 1 | 2017 | 514 | 0.030 |
Why?
| | Event-Related Potentials, P300 | 1 | 2013 | 17 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2015 | 430 | 0.030 |
Why?
| | Drug Interactions | 1 | 2015 | 405 | 0.020 |
Why?
| | Drug-Seeking Behavior | 1 | 2013 | 22 | 0.020 |
Why?
| | Thinness | 1 | 2014 | 100 | 0.020 |
Why?
| | Ambulatory Surgical Procedures | 1 | 1994 | 79 | 0.020 |
Why?
| | Retrospective Studies | 3 | 2019 | 17561 | 0.020 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1167 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2018 | 1253 | 0.020 |
Why?
| | Predictive Value of Tests | 2 | 2013 | 2133 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2022 | 1379 | 0.020 |
Why?
| | Motion | 1 | 2013 | 95 | 0.020 |
Why?
| | Quality Control | 1 | 2013 | 161 | 0.020 |
Why?
| | Evoked Potentials | 1 | 2013 | 132 | 0.020 |
Why?
| | Wechsler Scales | 1 | 2012 | 61 | 0.020 |
Why?
| | Acoustic Stimulation | 1 | 2013 | 334 | 0.020 |
Why?
| | Memory, Short-Term | 1 | 2014 | 271 | 0.020 |
Why?
| | Personality | 1 | 2013 | 131 | 0.020 |
Why?
| | Life Change Events | 1 | 2012 | 149 | 0.020 |
Why?
| | Image Enhancement | 1 | 2013 | 201 | 0.020 |
Why?
| | Alleles | 1 | 2014 | 909 | 0.020 |
Why?
| | Contraceptives, Oral | 1 | 2011 | 37 | 0.020 |
Why?
| | Psychological Tests | 1 | 2011 | 131 | 0.020 |
Why?
| | Respiratory Tract Diseases | 1 | 2012 | 178 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2974 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2013 | 742 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2011 | 374 | 0.020 |
Why?
| | Global Health | 1 | 2012 | 406 | 0.020 |
Why?
| | Temperance | 1 | 2009 | 20 | 0.020 |
Why?
| | Women's Health | 1 | 2011 | 317 | 0.020 |
Why?
| | Pain Measurement | 1 | 2011 | 569 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 2017 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 505 | 0.020 |
Why?
| | Precision Medicine | 1 | 2012 | 464 | 0.020 |
Why?
| | Administration, Cutaneous | 1 | 2007 | 127 | 0.020 |
Why?
| | Activities of Daily Living | 1 | 2011 | 449 | 0.020 |
Why?
| | Oxygen | 1 | 2012 | 998 | 0.020 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2006 | 29 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2006 | 145 | 0.010 |
Why?
| | Homosexuality | 1 | 2006 | 18 | 0.010 |
Why?
| | Cytosol | 1 | 2006 | 213 | 0.010 |
Why?
| | Twins, Dizygotic | 1 | 2006 | 108 | 0.010 |
Why?
| | Twins, Monozygotic | 1 | 2006 | 133 | 0.010 |
Why?
| | Parents | 1 | 2014 | 1428 | 0.010 |
Why?
| | Social Values | 1 | 2005 | 41 | 0.010 |
Why?
| | Stereotyping | 1 | 2005 | 42 | 0.010 |
Why?
| | Siblings | 1 | 2006 | 197 | 0.010 |
Why?
| | Virulence Factors | 1 | 2006 | 175 | 0.010 |
Why?
| | Nicotine | 1 | 2007 | 336 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 980 | 0.010 |
Why?
| | Data Collection | 1 | 2007 | 652 | 0.010 |
Why?
| | Endoplasmic Reticulum | 1 | 2006 | 269 | 0.010 |
Why?
| | Binding Sites | 1 | 2007 | 1319 | 0.010 |
Why?
| | Age Distribution | 1 | 2004 | 406 | 0.010 |
Why?
| | Sex Distribution | 1 | 2004 | 390 | 0.010 |
Why?
| | Ontario | 1 | 2002 | 91 | 0.010 |
Why?
| | Marital Status | 1 | 2002 | 47 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2006 | 1172 | 0.010 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2002 | 80 | 0.010 |
Why?
| | Poverty Areas | 1 | 2002 | 43 | 0.010 |
Why?
| | Parent-Child Relations | 1 | 2004 | 272 | 0.010 |
Why?
| | DNA | 1 | 2008 | 1444 | 0.010 |
Why?
| | Models, Educational | 1 | 2002 | 90 | 0.010 |
Why?
| | Fibroblasts | 1 | 2006 | 1040 | 0.010 |
Why?
| | Obstetrics | 1 | 2002 | 179 | 0.010 |
Why?
| | Gynecology | 1 | 2002 | 184 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2006 | 886 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2007 | 2625 | 0.010 |
Why?
| | Apoptosis | 1 | 2006 | 2454 | 0.010 |
Why?
| | Animals | 2 | 2012 | 38417 | 0.010 |
Why?
| | Ambulatory Care | 1 | 2001 | 625 | 0.010 |
Why?
| | Enflurane | 1 | 1994 | 4 | 0.010 |
Why?
| | Surgery, Oral | 1 | 1994 | 7 | 0.010 |
Why?
| | Halothane | 1 | 1994 | 8 | 0.010 |
Why?
| | Cohort Studies | 1 | 2004 | 6099 | 0.010 |
Why?
| | Isoflurane | 1 | 1994 | 41 | 0.010 |
Why?
| | Eye Movements | 1 | 1994 | 94 | 0.010 |
Why?
| | Propofol | 1 | 1994 | 88 | 0.010 |
Why?
| | Mice | 1 | 2006 | 18493 | 0.000 |
Why?
|
|
Bryan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|